Jose R. Maldonado, MD, FAPM, FACFE

Jose R. Maldonado, MD, FAPM, FACFE

Psychiatrist, Transplant psychiatrist

Bio:   Dr. Maldonado is Medical Director of Psychosomatic Medicine and Chief of Psychiatric Emergency Services and Transplant Psychiatry at Stanford University Medical Center. He is board certified in Adult Psychiatry, Psychosomatic Medicine, Forensic Psychiatry, Addiction Medicine, and Forensic Medicine. He is Chair of the Stanford School of Medicine – Faculty Senate and President of the American Delirium Society.

His research interests include: diagnosis, neurobiology, prevention and management of delirium; management of alcohol withdrawal in the medically-ill; psychosocial aspects of solid organ transplantation; and the medical use of hypnosis.

His research lab developed the Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) to assess the psychosocial candidacy of organ transplant and ventricular assisted devices (VADs). In a study of 102 randomly selected transplant cases, including liver, heart, and lung patients demonstrated that SIPAT scores highly predicted the transplant psychosocial outcome (P < 0.0001) and show the instrument to have excellent inter-rater reliability (Pearson's correlation coefficient = 0.853) (Maldonado JR, et al. The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT): a psychosocial evaluation tool for transplant candidates. Psychosomatics 2012; 53: 123–132). In the most recent study, Dr. Maldonado and his research lab have also analyzed data from 217 solid organ recipients who were all evaluated with SIPAT in pre-transplant setting and were then followed prospectively and found that SIPAT scores are correlated with 1-year post-surgery medical and psychosocial outcomes. In fact, the higher SIPAT scores were associated with higher incidence of various post-transplant medical complications, such as organ rejection episodes (p=.02), hospitalizations for medical reasons (p<.0001), infection rates (p=.02), as well as the occurrence of post-transplant psychosocial complications, such as psychiatric decompensation (p<.005), and failure of support system (p=0.02) (Maldonado JR, et al. The "Stanford Integrated Psychosocial Assessment for Transplantation" (SIPAT): A prospective study of medical and psychosocial outcomes”. Psychosomatic Medicine. 2015; 77(9):1018 - 1030).

In addition, his research has led the field of Psychosomatic Medicine with the development of tools for the prediction and assessment of various neuropsychiatric disorders; including the development of a new tool for the timely and accurate diagnosis of delirium: the Stanford Proxy Test of Delirium (S-PTD) [the only delirium assessment tool based on DSM-5 and ICD-10 criteria]; the Stanford Algorithm for Predicting Delirium (SAPD), a tool to help predict patients at risk for developing delirium; and the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) [a new tool for the prediction of patients at risk of severe AWS].

Finally, Dr Maldonado has written extensively on and developed management protocols and algorithms for the prevention and treatment of delirium; as well as novel pharmacological techniques (benzodiazepine-sparing protocol) for the prophylaxis and treatment of complicated alcohol withdrawal syndromes.

Liver Transplant Program

Outpatient Psychiatry Clinic

Kidney and Pancreas Transplant Program

  • 300 Pasteur Drive
  • 1st Floor, Suite A160
  • Stanford , CA 94305
  • Phone: 650-725-9891
More Clinic Information » Getting Here » Make An Appointment

Liver Transplant Program at Boswell Building

Heart Transplant Program

  • 300 Pasteur Drive
  • 2nd Floor, Room A260
  • Stanford , CA 94305
  • Phone: 650-723-5468
More Clinic Information » Getting Here » Make An Appointment

Stanford Hospital

Professional Education

  • Board Certification: Addiction Psychiatry, American Board of Addiction Medicine (2012)
  • Board Certification: Psychosomatic Medicine, American Board of Psychiatry and Neurology (2005)
  • Board Certification: Psychiatry, American Board of Psychiatry and Neurology (1993)
  • Fellowship: New England Medical Center (1993) MA
  • Residency: Temple University Hospital (1992) PA
  • Internship: Temple University Hospital (1989) PA
  • Medical Education: Ponce School Of Medicine (1988) PR
  • Diplomate, ABPN, Forensic Psychiatry (2005)
  • Diplomate, ABPN, Psychosomatic Medicine (2005)
  • Diplomate, American Board Forensic Examiner, Forensic Medicine (1996)
  • Diplomate, American Board Forensic Medicine, Forensic Medicine (1996)
  • Diplomate, ABPN, General Psychiatry (1993)
  • Fellowship, New England Medical Center, Psychosomatic Medicine (1993)
  • Resident, Temple University Hospital, Residency in Psychiatry (1992)
  • MD, Ponce School of Medicine, Medicine (1988)

Honors & Awards

  • 2001-Teacher of the Year Award, Psychiatric Times (2001)
  • 2003 Kaiser Awards for Clinical Teaching, Stanford University School of Medicine (2003)
  • Best Paper on the Application of Hypnosis, American Psychological Association (2002)
  • Best Researcher/Author Presentation, 17th World Congress on Psychosomatic Medicine (2003)
  • Charles Shagass, MD Award, for meritorious scholarly work during residency, Temple University School of Medicine (1992)
  • Dlin/Fischer Award for significant achievement in Clinical Research, Academy of Psychosomatic Medicine (2014)
  • DLIN/Fischer Award, for significant achievement in clinical research, Academy of Psychosomatic Medicine (2004)
  • Dorfman Award for Best Original Research, Academy of Psychosomatic Medicine (2009)
  • Dorfman Award, for Best Case Report, Academy of Psychosomatic Medicine (2006)
  • Fellow, Academy of Psychosomatic Medicine (1996)
  • Fellow, American College of Forensic Psychiatry (1996)
  • Franz-Köhler-Inflammation-Award, German Society of Anaesthesiology and Intensive Care Medicine (2017)
  • Herbert Spiegel Award for Hypnosis Research, Department of Psychiatry at Columbia University & New York State Psychiatric Institute (2014)
  • Research Poster of the Year Award, Academy of Psychosomatic Medicine (2012)
  • Research Poster of the Year Award, Academy of Psychosomatic Medicine (2014)
  • Research Poster of the Year Award, Society for Academic Emergency Medicine (2013)
  • Sawlow Memorial Award on Neuroscience, Oregon Health & Science University and the Portland International Neuroscience Symposium (2016)
  • Teacher of the Year Award, Department of Psychiatry & Behavioral Sciences, Stanford University (2004)
  • Teacher of the Year Award, Department of Psychiatry & Behavioral Sciences, Stanford University (2009)
  • Visiting Professorship Award, Academy of Psychosomatic Medicine (2014)

Administrative Appointments

  • Admissions Panel, Stanford University Medical School (1998 - 2008)
  • Chair, Ethics Committee, Society for Clinical and Experimental Hypnosis (1995 - 1997)
  • Chair, Stanford School of Medicine Faculty Senate, Stanford School of Medicine (2016 - 2018)
  • Chief, Psychiatry Emergency Service, Stanford Hospital & Clinics (2015 - Present)
  • Co-Chair, Ethics Committee, Stanford University Medical Center (2001 - 2009)
  • Committee on Xenotransplantation, The Secretary of Health & Human Services (2004 - 2008)
  • Departmental Senator, Psychiatry, Stanford School of Medicine (2011 - Present)
  • Fellowship Director, Psychosomatic Medicine Program, Stanford School of Medicine (2010 - Present)
  • Medical Director, Psychosomatic Medicine Service, Stanford Hospital and Clinic (1995 - Present)
  • Member, Board of Directors, American Delirium Society (2012 - Present)
  • National Panel on Transplantation, National Institute of Health (2004 - 2008)
  • President, American Delirium Society (2017 - 2018)
  • Senator-at-Large, Stanford School of Medicine (2009 - 2013)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.